At-home STI testing market seen reaching $3.55 billion by 2030

The Business Research Company says the at-home sexually transmitted infection testing market is growing quickly as consumers seek more private and convenient screening options. The market is projected to rise from $1.93 billion in 2025 to $3.55 billion by 2030, driven by telehealth, rapid kits and expanding direct-to-consumer channels.

Why it matters: - At-home STI testing is moving sexual health screening out of clinics and into private, consumer-friendly settings. - The market’s growth signals stronger demand for confidential, accessible testing as STI awareness and preventive care expand. - Rising adoption could broaden early diagnosis and treatment for infections that often go undetected.

What happened: - The Business Research Company released a report on the global at-home sexually transmitted infection testing market on June 29, 2026. - The market is projected to grow from $1.93 billion in 2025 to $2.17 billion in 2026. - The report forecasts the market will reach $3.55 billion by 2030. - The company projects a 12.8% compound annual growth rate in 2026 and 13.0% CAGR over the longer forecast period. - North America was the largest regional market in 2025. - Asia-Pacific is expected to post the fastest growth through the forecast period.

The details: - At-home STI testing kits let users collect samples privately and either mail them to certified labs or use rapid at-home methods. - The products are designed to improve accessibility, confidentiality and convenience in STI screening. - The market’s recent growth has been driven by higher STI prevalence, greater awareness of early diagnosis, expanded use of telemedicine and online healthcare, stronger public health screening efforts and consumer preference for home-based care. - The report expects further growth from AI-powered sexual health platforms, multiplex and rapid diagnostic kits, connected and app-based testing systems, direct-to-consumer distribution and preventive screening habits. - Key trends include discreet self-collection kits, rapid diagnostic tools, mail-in laboratory testing, multi-infection test panels and online pharmacy channels. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report is available through the company’s announcement and a free sample request.

Between the lines: - The forecast suggests at-home testing is becoming a mainstream part of sexual health infrastructure, not just a niche privacy product. - Demand for faster, multi-condition and app-connected kits points to consumers wanting more than simple test-and-wait convenience. - The cited rise in infectious syphilis cases in the UK underscores why public health groups continue to push easier access to screening.

What's next: - The market’s next phase will likely hinge on how quickly consumers adopt multiplex kits, app-linked systems and direct-to-consumer channels. - Growth in Asia-Pacific could reshape where providers focus investment, distribution and product development. - Wider routine screening could keep lifting demand if public health campaigns continue to reduce stigma around STI testing.

The bottom line: - At-home STI testing is on track for double-digit growth through 2030, powered by privacy, convenience and the expansion of digital health tools.